Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Fiji.
Press releases published on July 16, 2025
Gain Therapeutics Announces Pricing of $7.0 Million Public Offering
GlobeNewswire
·
July 16, 2025
BETHESDA, Md., July 16, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …
Lattimore Physical Therapy & Sports Rehabilitation Network Rolls Out Athelas Air to 35 Locations
GlobeNewswire
·
July 16, 2025
MOUNTAIN VIEW, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Athelas, healthcare technology company powered by Commure, today announced the successful deployment of its unified EHR platform, Athelas Air, at Lattimore Physical Therapy …
Ensemble Announces Strategic Revenue Cycle Partnership with Methodist Le Bonheur Healthcare
GlobeNewswire
·
July 16, 2025
CINCINNATI, Ohio, July 16, 2025 (GLOBE NEWSWIRE) -- Ensemble, the nation’s leading revenue cycle managed services partner for healthcare organizations, announced today that Methodist Le Bonheur Healthcare (MLH) has selected it as its strategic revenue …
Following Psychedelic Science 2025 Success, MAPS Publishes First of Hundreds of Conference Session Videos
GlobeNewswire
·
July 16, 2025
Enhanced Virtual Trip platform goes live with improved user experience and first selection of PS2025 session videos Conference drew 8,000+ attendees, more than $1 million donated, and 1,100+ recurring donors joined the new membership program MAPS …
CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY
GlobeNewswire
·
July 16, 2025
Kuala Lumpur, Malaysia, July 16, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today commented on recent stock price …
DIAGNOS Files FDA Pre-Submission for its CARA System: Strategic Entry into the U.S. Optometry Market with Support from ORA LLC
GlobeNewswire
·
July 16, 2025
BROSSARD, Quebec, July 16, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Canadian leader in artificial intelligence (AI) for the early detection of retinal and systemic diseases, is …
DIAGNOS dépose une pré-soumission auprès de la FDA pour son système CARA : Entrée stratégique sur le marché américain de l'optométrie avec le soutien d'ORA LLC
GlobeNewswire
·
July 16, 2025
BROSSARD, Québec, 16 juill. 2025 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK, OTCQB : DGNOF, FWB : 4D4A), un leader canadien de l'intelligence artificielle (IA) pour la détection précoce des maladies …
BioAdaptives Announces National Launch of NeuroRush™ — A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience
GlobeNewswire
·
July 16, 2025
LAS VEGAS, July 16, 2025 (GLOBE NEWSWIRE) -- BioAdaptives, Inc. (OTC: BDPT), an innovator in evidence-based wellness solutions, today announced the upcoming national release of NeuroRush™, a next-generation nootropic designed to support sustained cognitive …
Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15
GlobeNewswire
·
July 16, 2025
SARASOTA, FL, July 16, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced completion of dosing in a U …
SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry
GlobeNewswire
·
July 16, 2025
Highest Rated Children’s Medical Centers Now Employ QUELIMMUNE for Ultra-Rare Cases of Pediatric AKI HDE Surveillance Registry Data Captures Key Metrics for Future Analysis of QUELIMMUNE Performance DENVER, July 16, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical …
Henry Ford Health Initiates Patient Enrollment for BioCardia’s CardiAMP HF II Pivotal Study for Ischemic Heart Failure of Reduced Ejection Fraction
GlobeNewswire
·
July 16, 2025
SUNNYVALE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced today that Henry Ford Health in Detroit, …
Silexion Therapeutics Announces 1-for-15 Reverse Share Split
GlobeNewswire
·
July 16, 2025
Grand Cayman, Cayman Islands, July 16, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today …
Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical Development
GlobeNewswire
·
July 16, 2025
SARASOTA, Fla., July 16, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced it has entered into a manufacturing agreement with Sterling …
Intelligent Bio Solutions Accelerates Global Growth with SmarTest® Patch Agreement, Reinforces U.S. Expansion Path as FDA Approval Remains a Strategic Priority
GlobeNewswire
·
July 16, 2025
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced a new global distribution …
Adial Pharmaceuticals Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement
GlobeNewswire
·
July 16, 2025
GLEN ALLEN, Va., July 16, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related …
TOMI Environmental Solutions Advances New Product, SteraMist Integration System – Standalone (SIS-SA)
GlobeNewswire
·
July 16, 2025
FREDERICK, Md., July 16, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced the successful first installation of its new …
Vystar Launches New Website and Unveils Brand Refresh www.vytex.com
GlobeNewswire
·
July 16, 2025
Boston, MA, July 16, 2025 (GLOBE NEWSWIRE) -- Vystar® Corporation (OTCQB: VYST) Vytex manufacturer Vystar has today launched a newly-redesigned website www.vytex.com to work alongside the new brand refresh and overall digital strategy. The completely …
Safety Shot Receives 180-Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Requirement
GlobeNewswire
·
July 16, 2025
SCOTTSDALE, AZ, July 16, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or the “Company”) today announced it has received a notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") …
Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement
GlobeNewswire
·
July 16, 2025
CINCINNATI, July 16, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) and Ocuvex Therapeutics, Inc. (“Ocuvex”), a privately held biopharmaceutical company focused on the development and commercialization of ophthalmic …
Scienture Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements
GlobeNewswire
·
July 16, 2025
Commack, NY, July 16, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”) a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers …